Clal Biotechnology Industries Ltd (TA:CBI) — Stock Price
Clal Biotechnology Industries Ltd (TA:CBI) is currently trading at ILA24.90 ILA, up 1.63% today. Over the past 52 weeks, shares have ranged between ILA24.20 and ILA42.50. This page tracks Clal Biotechnology Industries Ltd's live share price on the TA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Clal Biotechnology Industries Ltd (CBI) market capitalisation.
Clal Biotechnology Industries Ltd (CBI) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Clal Biotechnology Industries Ltd's daily closing share price and trading volume on the TA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Clal Biotechnology Industries Ltd Income Statement — Revenue, Profit & Earnings by Year
Clal Biotechnology Industries Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | ILA433.00K | ILA104.00K | ILA370.00K | ILA224.00K | ILA206.00K |
| Cost of Revenue | ILA616.00K | — | ILA21.87 Million | ILA66.24 Million | ILA68.33 Million |
| Gross Profit | ILA-183.00K | ILA104.00K | ILA370.00K | ILA224.00K | ILA206.00K |
| Research & Development | — | — | ILA24.81 Million | ILA33.07 Million | ILA26.35 Million |
| SG&A | ILA4.03 Million | ILA5.48 Million | ILA6.51 Million | ILA14.35 Million | ILA13.17 Million |
| Total Operating Expenses | ILA6.34 Million | ILA10.29 Million | ILA12.27 Million | ILA77.47 Million | ILA10.30 Million |
| Operating Income | ILA-6.34 Million | ILA-10.18 Million | ILA-27.42 Million | ILA-77.59 Million | ILA40.15 Million |
| EBITDA | ILA-6.34 Million | ILA-24.02 Million | ILA64.22 Million | ILA-55.08 Million | ILA13.23 Million |
| EBIT | ILA-6.63 Million | ILA-24.55 Million | ILA46.57 Million | ILA-77.59 Million | ILA-10.64 Million |
| Interest Expense | ILA3.40 Million | ILA3.54 Million | ILA3.73 Million | ILA1.76 Million | ILA4.26 Million |
| Income Before Tax | ILA-75.07 Million | ILA-28.09 Million | ILA-41.02 Million | ILA-66.59 Million | ILA49.84 Million |
| Income Tax Expense | — | — | ILA113.95 Million | ILA89.00K | — |
| Net Income | ILA-62.46 Million | ILA-31.05 Million | ILA-61.74 Million | ILA-89.58 Million | ILA109.03 Million |
Clal Biotechnology Industries Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Clal Biotechnology Industries Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | ILA67.69 Million | ILA158.39 Million | ILA182.69 Million | ILA444.92 Million | ILA614.03 Million |
| Total Current Assets | ILA5.80 Million | ILA14.69 Million | ILA16.64 Million | ILA77.61 Million | ILA211.09 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | ILA1.06 Million | ILA7.63 Million | ILA5.44 Million | — | ILA118.34 Million |
| Net Receivables | ILA505.00K | ILA512.00K | ILA3.99 Million | ILA8.53 Million | ILA10.81 Million |
| Inventory | — | — | — | ILA3.73 Million | ILA4.44 Million |
| Property, Plant & Equipment | — | — | ILA5.09 Million | ILA18.06 Million | ILA14.94 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | ILA21.52 Million | ILA36.98 Million | ILA37.79 Million | ILA106.55 Million | ILA100.24 Million |
| Total Current Liabilities | ILA20.00 Million | ILA6.66 Million | ILA2.91 Million | ILA35.65 Million | ILA28.28 Million |
| Long-term Debt | ILA0.00 | ILA25.96 Million | ILA27.39 Million | — | — |
| Net Debt | ILA16.89 Million | ILA30.03 Million | ILA1.90 Million | ILA-41.37 Million | ILA-60.42 Million |
| Total Stockholder Equity | ILA36.63 Million | ILA99.36 Million | ILA126.03 Million | ILA172.59 Million | ILA306.35 Million |
| Retained Earnings | ILA-1.39 Billion | ILA-1.33 Billion | ILA-1.30 Billion | ILA-1.24 Billion | ILA-1.11 Billion |
Clal Biotechnology Industries Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Clal Biotechnology Industries Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | ILA-6.48 Million | ILA-8.51 Million | ILA-59.04 Million | ILA-41.33 Million | ILA-33.23 Million |
| Capital Expenditures | ILA0.00 | ILA5.00K | ILA1.27 Million | ILA1.59 Million | ILA3.19 Million |
| Free Cash Flow | ILA-6.48 Million | ILA-8.52 Million | ILA-60.31 Million | ILA-42.92 Million | ILA-36.41 Million |
| Investing Cash Flow | ILA20.00 Million | ILA7.66 Million | ILA-10.96 Million | ILA79.18 Million | ILA70.78 Million |
| Financing Cash Flow | ILA-15.55 Million | ILA-1.18 Million | ILA20.05 Million | ILA-51.54 Million | ILA-2.38 Million |
| Dividends Paid | — | — | — | ILA36.00 Million | ILA36.00 Million |
| Stock-Based Compensation | — | ILA40.00K | ILA5.15 Million | ILA5.55 Million | ILA5.54 Million |
| Depreciation | ILA283.00K | ILA526.00K | ILA17.64 Million | ILA22.51 Million | ILA23.87 Million |
| Change in Cash | ILA-1.78 Million | ILA-1.71 Million | ILA-45.61 Million | ILA-15.11 Million | ILA30.61 Million |
Clal Biotechnology Industries Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Clal Biotechnology Industries Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Nov 19, 2020 | -0.11 | — | — |
| May 14, 2015 | -0.21 | -0.16 | -31.25% |
| Dec 31, 2014 | -1.70 | -0.28 | -497.29% |
| Nov 13, 2014 | -3.59 | -0.29 | -1137.93% |
| Aug 19, 2014 | 0.30 | 0.40 | -25.00% |
| May 22, 2014 | -0.39 | -0.16 | -143.75% |
| Nov 14, 2013 | -0.32 | -0.18 | -77.78% |